An Implementation and Biobehavioral Study of Temporomandibular Joint and Muscle Disorder (TMJMD)
|ClinicalTrials.gov Identifier: NCT00952900|
Recruitment Status : Completed
First Posted : August 6, 2009
Last Update Posted : June 8, 2015
|Condition or disease||Intervention/treatment|
|Temporomandibular Joint and Muscle Disorder||Behavioral: Biobehavioral Behavioral: Active Coping/Attention Intervention|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||456 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||An Implementation and Biobehavioral Study of TMJMD|
|Study Start Date :||August 2008|
|Primary Completion Date :||October 2013|
|Study Completion Date :||July 2014|
Experimental: Early Biobehavioral Intervention
This intervention involves the use of non-invasive treatment modalities such as relaxation/biofeedback, stress management, and cognitive coping skills. It is based upon previous clinical research studies demonstrating the efficacy of this intervention in allowing acute TMD patients to better cope with stress and lifestyle issues that produce the TMD pain/discomfort.
6 sessions of Biobehavioral treatment modalities that include relaxation/biofeedback, stress management, and coping skills techniques.
Active Comparator: Attention Control Group
This intervention involves the presentation of helpful information to patients that explains etiology and potential treatment modalities used to modify/reduce TMD pain/discomfort.
Behavioral: Active Coping/Attention Intervention
6 sessions of didactic educational techniques to expose patients to the causes of TMD, as well as introducing them to traditional treatment modalities for intervening with acute TMD problems.
No Intervention: No Active Treatment Comparison Group
Unlike the other two treatment groups, that involve high-risk acute TMD patients, this group includes low-risk acute TMD patients. Past studies have shown that these low risk patients do not need any early intervention in order to prevent chronicity.
- Acute TMJMD does not progress to chronic [ Time Frame: 24 months ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00952900
|United States, Texas|
|Arlington, Texas, United States, 76019|
|Principal Investigator:||Robert J. Gatchel, Ph.D., ABPP||The University of Texas at Arlington|